Neurologists’ decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices
| dc.contributor.author | Gutiérrez Gutiérrez, Gerardo | |
| dc.contributor.author | Gómez Ballesteros, Rocío | |
| dc.contributor.author | Ares, Adrián | |
| dc.contributor.author | Villaverde, Ramón | |
| dc.contributor.author | Reyes, Virginia | |
| dc.contributor.author | Armangué, Thaís | |
| dc.contributor.author | Díaz Abós, Paola | |
| dc.contributor.author | Rebollo, Pablo | |
| dc.contributor.author | Canal, Neus | |
| dc.contributor.author | Et. al. | |
| dc.date.accessioned | 2026-02-20T12:25:19Z | |
| dc.date.available | 2026-02-20T12:25:19Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | The evolving landscape of generalised myasthenia gravis (gMG) treatment with new targeted immunotherapy options presents challenges for neurologists and potentially leads to therapeutic inertia (TI), the failure to initiate or intensify treatment when therapeutic goals are not met. This study aimed to assess neurologists’ therapeutic decision-making process in gMG and its influencing factors. A cross-sectional, web-based study was conducted, involving 149 neurologists. | en |
| dc.description.filiation | UEM | spa |
| dc.description.impact | 3.4 Q2 JCR 2024 | |
| dc.description.impact | 1.016 Q2 SJR 2024 | |
| dc.description.impact | No data IDR 2024 | |
| dc.description.sponsorship | Roche Medical Department SL45180 | en |
| dc.identifier.citation | Gutiérrez-Gutiérrez, G., Gómez-Ballesteros, R., Ares, A., Villaverde, R., Reyes, V., Armangué, T., Díaz-Abós, P., Rebollo, P., Canal, N., Querol, L., Maurino, J., & Cortés-Vicente, E. (2026). Neurologists’ decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices. Journal of Neuromuscular Diseases, 22143602261420993. https://doi.org/10.1177/22143602261420993 | |
| dc.identifier.doi | 10.1177/22143602261420993 | |
| dc.identifier.issn | 2214-3599 | |
| dc.identifier.issn | 2214-3602 | |
| dc.identifier.uri | https://hdl.handle.net/11268/16860 | |
| dc.language.iso | eng | |
| dc.peerreviewed | Si | |
| dc.relation.publisherversion | https://doi.org/10.1177/22143602261420993 | |
| dc.rights | Attribution-NonCommercial 4.0 International | en |
| dc.rights.accessRights | open access | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
| dc.subject.other | Miastenia gravis | |
| dc.subject.other | Toma de decisiones clínicas | |
| dc.subject.other | Neurólogos | |
| dc.subject.sdg | Goal 3: Ensure healthy lives and promote well-being for all at all ages | |
| dc.subject.unesco | Neurología | |
| dc.subject.unesco | Personal médico | |
| dc.subject.unesco | Medicina preventiva | |
| dc.title | Neurologists’ decision-making in the management of generalised myasthenia gravis: Therapeutic inertia and treatment choices | |
| dc.type | journal article | |
| dc.type.hasVersion | VoR | |
| dspace.entity.type | Publication | |
| relation.isAuthorOfPublication | b7557616-3760-45a7-a37d-86eb9a29e434 | |
| relation.isAuthorOfPublication.latestForDiscovery | b7557616-3760-45a7-a37d-86eb9a29e434 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Neurologists' decision-making_2026
- Size:
- 866.91 KB
- Format:
- Adobe Portable Document Format

